Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liuxi Chen

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|April 27, 2024
Evaluation of Patient-Centric Sample Collection Technologies for Pharmacokinetic Assessment of Large and Small MoleculesSandhya Mandlekar, Dhruvitkumar S Sutaria, Xiaoyun Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 15, 2026
Ketone reduction drives major circulating metabolites of GDC-8264 in humansShuai Wang, Susan Wong, Antonio DiPasquale, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 8, 2020
Validation of the NEOS score in Chinese patients with anti-NMDAR encephalitisYujing Peng, Feifei Dai, Lei Liu, et al.
Clinical and Translational Science|February 14, 2022
Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC-0214 in healthy volunteersRui Zhu, Hubert Chen, Joshua Galanter, et al.
Medicine|March 17, 2020
Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancer: A Meta-analysisYing Liu, Liuxi Chen, Ruonan Zhang, et al.
Clinical and Translational Science|May 31, 2021
Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitorPhyllis Chan, Han Ting Ding, Bianca M Liederer, et al.
Clinical and Translational Science|June 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteersFei Tang, Rebecca Kunder, Tom Chu, et al.
Journal of Cancer|August 4, 2020
Correlation of PD-L1 and SOCS3 Co-expression with the Prognosis of Hepatocellular Carcinoma PatientsLiuxi Chen, Xingxing Huang, Wenzheng Zhang, et al.
Journal of Bacteriology|September 5, 2024
Differential effects of inosine monophosphate dehydrogenase (IMPDH/GuaB) inhibition in <i>Acinetobacter baumannii</i> and <i>Escherichia coli</i>Yutian Peng, John G Moffat, Cory DuPai, et al.
Frontiers in Bioengineering and Biotechnology|May 28, 2020
β-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle ArrestRuonan Zhang, Ting Pan, Yu Xiang, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|April 27, 2024
Evaluation of Patient-Centric Sample Collection Technologies for Pharmacokinetic Assessment of Large and Small MoleculesSandhya Mandlekar, Dhruvitkumar S Sutaria, Xiaoyun Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 15, 2026
Ketone reduction drives major circulating metabolites of GDC-8264 in humansShuai Wang, Susan Wong, Antonio DiPasquale, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 8, 2020
Validation of the NEOS score in Chinese patients with anti-NMDAR encephalitisYujing Peng, Feifei Dai, Lei Liu, et al.
Clinical and Translational Science|February 14, 2022
Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC-0214 in healthy volunteersRui Zhu, Hubert Chen, Joshua Galanter, et al.
Medicine|March 17, 2020
Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancer: A Meta-analysisYing Liu, Liuxi Chen, Ruonan Zhang, et al.
Clinical and Translational Science|May 31, 2021
Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitorPhyllis Chan, Han Ting Ding, Bianca M Liederer, et al.
Clinical and Translational Science|June 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteersFei Tang, Rebecca Kunder, Tom Chu, et al.
Journal of Cancer|August 4, 2020
Correlation of PD-L1 and SOCS3 Co-expression with the Prognosis of Hepatocellular Carcinoma PatientsLiuxi Chen, Xingxing Huang, Wenzheng Zhang, et al.
Journal of Bacteriology|September 5, 2024
Differential effects of inosine monophosphate dehydrogenase (IMPDH/GuaB) inhibition in <i>Acinetobacter baumannii</i> and <i>Escherichia coli</i>Yutian Peng, John G Moffat, Cory DuPai, et al.
Frontiers in Bioengineering and Biotechnology|May 28, 2020
β-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle ArrestRuonan Zhang, Ting Pan, Yu Xiang, et al.
Pageof 5